Literature DB >> 20399963

Androgen regulation of gene expression.

Kristin R Lamont1, Donald J Tindall.   

Abstract

The biological action of androgenic male sex steroid hormones in prostate tissue is mediated by the androgen receptor, a nuclear transcription factor. The transcriptional program of androgenic signaling in the prostate consists of thousands of gene targets whose products play a role in almost all cellular functions, including cellular proliferation, survival, lipid metabolism, and differentiation. This review will provide a summary of the most recent data regarding androgen-regulated target genes and modulation of androgen receptor activity, especially with regard to androgen-dependent and castration-recurrent prostate cancer. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399963     DOI: 10.1016/S0065-230X(10)07005-3

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  43 in total

1.  The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.

Authors:  Hongbo Wang; Ming Jiang; Hongmei Cui; Mengqian Chen; Ralph Buttyan; Simon W Hayward; Tsonwin Hai; Zhengxin Wang; Chunhong Yan
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

Review 2.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

3.  Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.

Authors:  Zehua Wang; Zemin Wang; Jianhui Guo; Yingchun Li; Jasmin H Bavarva; Chiping Qian; M Christiane Brahimi-Horn; Deyong Tan; Wanguo Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

4.  Methoxychalcone inhibitors of androgen receptor translocation and function.

Authors:  Yeong Sang Kim; Vineet Kumar; Sunmin Lee; Aki Iwai; Len Neckers; Sanjay V Malhotra; Jane B Trepel
Journal:  Bioorg Med Chem Lett       Date:  2012-01-21       Impact factor: 2.823

5.  Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.

Authors:  Howard I Scher; Ryon P Graf; Nicole A Schreiber; Brigit McLaughlin; David Lu; Jessica Louw; Daniel C Danila; Lyndsey Dugan; Ann Johnson; Glenn Heller; Martin Fleisher; Ryan Dittamore
Journal:  Eur Urol       Date:  2016-12-12       Impact factor: 20.096

Review 6.  The role of the prostate in male fertility, health and disease.

Authors:  Paolo Verze; Tommaso Cai; Stefano Lorenzetti
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

7.  The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.

Authors:  Sathish Kasina; Jill A Macoska
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

Review 8.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

9.  In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancer.

Authors:  Howard C Shen; Kumaran Shanmugasundaram; Nicholas I Simon; Changmeng Cai; Hongyun Wang; Sen Chen; Steven P Balk; Alan C Rigby
Journal:  Mol Endocrinol       Date:  2012-09-28

10.  ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.

Authors:  Changmeng Cai; Hongyun Wang; Housheng Hansen He; Sen Chen; Lingfeng He; Fen Ma; Lorelei Mucci; Qianben Wang; Christopher Fiore; Adam G Sowalsky; Massimo Loda; X Shirley Liu; Myles Brown; Steven P Balk; Xin Yuan
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.